.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Queensland Health
QuintilesIMS
Moodys
Merck
US Army
Deloitte
US Department of Justice
Daiichi Sankyo
McKinsey

Generated: June 25, 2017

DrugPatentWatch Database Preview

Chlorpheniramine polistirex; hydrocodone polistirex - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine polistirex; hydrocodone polistirex and what is the scope of chlorpheniramine polistirex; hydrocodone polistirex freedom to operate?

Chlorpheniramine polistirex; hydrocodone polistirex
is the generic ingredient in four branded drugs marketed by Ucb Inc, Tris Pharma Inc, Neos Therap Inc, and Ecr Pharma, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine polistirex; hydrocodone polistirex. Eight suppliers are listed for this compound.

Summary for Generic Name: chlorpheniramine polistirex; hydrocodone polistirex

Tradenames:4
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list29
Suppliers / Packagers: see list8
Clinical Trials: see list109
Drug Prices:see low prices
DailyMed Link:chlorpheniramine polistirex; hydrocodone polistirex at DailyMed

Pharmacology for Ingredient: chlorpheniramine polistirex; hydrocodone polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc
HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
chlorpheniramine polistirex; hydrocodone polistirex
SUSPENSION, EXTENDED RELEASE;ORAL091632-001Oct 1, 2010ABRXNoNo► Subscribe► Subscribe
Ecr Pharma
TUSSICAPS
chlorpheniramine polistirex; hydrocodone polistirex
CAPSULE, EXTENDED RELEASE;ORAL077273-001Sep 24, 2007RXNoYes► Subscribe► Subscribe
Neos Therap Inc
HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX
chlorpheniramine polistirex; hydrocodone polistirex
SUSPENSION, EXTENDED RELEASE;ORAL091671-001Jun 29, 2012ABRXNoNo► Subscribe► Subscribe
Ecr Pharma
TUSSICAPS
chlorpheniramine polistirex; hydrocodone polistirex
CAPSULE, EXTENDED RELEASE;ORAL077273-002Sep 24, 2007RXNoNo► Subscribe► Subscribe
Ucb Inc
TUSSIONEX PENNKINETIC
chlorpheniramine polistirex; hydrocodone polistirex
SUSPENSION, EXTENDED RELEASE;ORAL019111-001Dec 31, 1987ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: chlorpheniramine polistirex; hydrocodone polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
TUSSIONEX PENNKINETIC
chlorpheniramine polistirex; hydrocodone polistirex
SUSPENSION, EXTENDED RELEASE;ORAL019111-001Dec 31, 19874,221,778► Subscribe
Ucb Inc
TUSSIONEX PENNKINETIC
chlorpheniramine polistirex; hydrocodone polistirex
SUSPENSION, EXTENDED RELEASE;ORAL019111-001Dec 31, 19874,762,709► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
McKesson
Medtronic
Federal Trade Commission
Daiichi Sankyo
Accenture
Johnson and Johnson
Fuji
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot